Table 1 Baseline characteristics of patients treated for protected and unprotected LMCA disease using SES.
| Characteristics | Protected LMCA (n = 118) | Unprotected LMCA (n = 82) | p Value |
|---|---|---|---|
| Male (%) | 76.3 | 72.8 | 0.6 |
| Age (years), median | 66.7 | 69.5 | 0.3 |
| Diabetes mellitus (%) | 34.7 | 22.8 | 0.07 |
| Renal insufficiency (%) | 15.4 | 13.8 | 0.8 |
| BMI (kg/m2), median | 27 | 25 | 0.003 |
| Hypertension (%) | 86.2 | 84.6 | 0.8 |
| Hypercholesterolaemia (%) | 94 | 81.8 | 0.008 |
| Current smoking (%) | 15.6 | 23.9 | 0.2 |
| Previous MI (%) | 42.2 | 22.8 | 0.006 |
| Left ventricular EF ⩽40 (%) | 25.6 | 29.4 | 0.6 |
| STEMI (%) | 4.2 | 8.6 | 0.2 |
| NSTEMI (%) | 10.2 | 18. | 0.09 |
| Unstable angina pectoris (%) | 22 | 21 | 0.9 |
| Cardiogenic shock (%) | 0.8 | 2.5 | 0.4 |
BMI, body mass index; EF, ejection fraction; LMCA, left main coronary artery; MI, myocardial infarction; NSTEMI, non‐ST‐elevation myocardial infarction; STEMI, ST‐elevation myocardial infarction.